Please provide your email address to receive an email when new articles are posted on . Dexrazoxane appeared to have a cardioprotective effect almost 2 decades after exposure to anthracyclines among a ...

High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients. Between November 1988 and ...

Natural history of node-positive breast cancer: the curability of small cancers with a limited number of positive nodes. Dexrazoxane was found effective in reducing doxorubicin cardiotoxicity when ...

Although the phosphatidyl-inositol-3-kinase (PI3K)/Akt pathway is essential for conferring cardioprotection in response to ischemic preconditioning (IP), the role of PI3K/Akt signaling in the ...

Dexrazoxane (Totect, Zinecard) provides long-term cardioprotection for children treated with doxorubicin for cancer, and its co-administration with doxorubicin should be standard of care, say ...

What is the best choice for cardioprotection in a woman aged 75 years with episodic symptomatic angina, MI one year earlier and a sensitivity to nitroglycerin patches (i.e., skin erythema, burning, ...

Please provide your email address to receive an email when new articles are posted on . Soy protein plus ketoanalogues of essential amino acids produced a larger effect on nephroprotection and ...

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Test to be used in the RAC-010 trial to assess RC220’s ability to protect molecular pathways from anthracycline cardiotoxicity Racura Oncology (ASX:RAC) said the new test would be used in the ongoing ...

Heart attacks are a leading cause of death and disability in Europe, and their effects often extend beyond the initial event, leading to chronic heart failure. To address this urgent public health ...